bioMérieux Acquires SpinChip Diagnostics
bioMérieux has acquired SpinChip Diagnostics ASA, which has a POC immunoassay platform capable of delivering results within 10 minutes.
Read MorePosted by Chris Wolski | Jan 31, 2025 | POC Rapid Assays |
bioMérieux has acquired SpinChip Diagnostics ASA, which has a POC immunoassay platform capable of delivering results within 10 minutes.
Read MorePosted by Andy Lundin | Jan 30, 2025 | Womens Health |
The Mirvie RNA platform identified a unique molecular signature predictive of severe fetal growth restriction, allowing early detection.
Read MorePosted by Andy Lundin | Jan 27, 2025 | Cardiovascular, Immunoassay Reagents & test Kits |
Abbott’s Alere NT-proBNP assay for Alinity i is a new tool for heart failure diagnosis, providing accurate results and improved efficiency.
Read MorePosted by Andy Lundin | Jan 27, 2025 | Covid 19 |
CovarsaDx supported OSANG Healthcare in securing FDA clearance for the QuickFinder COVID-19/Flu Antigen Self-Test and Pro Test.
Read MorePosted by Andy Lundin | Jan 24, 2025 | Molecular Diagnostics |
Researchers identified blood biomarkers associated with Sudden Infant Death Syndrome, paving the way for diagnostic tests for infants.
Read More